Inari Medical shares are trading lower after the company reported Q2 financial results and issued FY24 revenue guidance below estimates.
Portfolio Pulse from Benzinga Newsdesk
Inari Medical shares are trading lower after the company reported Q2 financial results and issued FY24 revenue guidance below estimates.
July 30, 2024 | 8:54 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Inari Medical shares are trading lower due to disappointing Q2 financial results and FY24 revenue guidance below estimates.
The company's Q2 financial results did not meet market expectations, and the FY24 revenue guidance was below estimates. This negative news is likely to cause a short-term decline in the stock price as investors react to the disappointing performance and outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100